Trial Outcomes & Findings for Effect IV Ibuprofen and Inflammatory Responses (NCT NCT01938040)

NCT ID: NCT01938040

Last Updated: 2016-12-21

Results Overview

Serum concentration of cortisol, CRP, drawn in Post Anesthesia Care unit at 2 hours following surgery were compared with those same levels drawn preoperatively and intraoperatively.

Recruitment status

COMPLETED

Study phase

PHASE4

Target enrollment

60 participants

Primary outcome timeframe

2 hours following end of surgery

Results posted on

2016-12-21

Participant Flow

60 patients were recruited from the Same Day Surgery Unit at three hospital locations. The dates of recruitment were from 12/1/2011 to 10/2/13.

Of the 60 patients randomized 5 did not receive study medication. The surgical case was either cancelled or the subjects withdrew consent.

Participant milestones

Participant milestones
Measure
Caldolor/Ibuprofen
800mg administered IV in 100mL normal saline over 5 minutes prior to surgical incision.
Placebo
100mL of normal saline to be administered intravenously over 5 minutes prior to surgical incision.
Overall Study
STARTED
28
27
Overall Study
Plasma Analysis
24
25
Overall Study
Behavior Metrics
28
27
Overall Study
COMPLETED
28
27
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Effect IV Ibuprofen and Inflammatory Responses

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Ibuprofen/Caldolor
n=28 Participants
800mg administered IV in 100cc of normal saline over 5 minutes ibuprofen: single preoperative dose prior to surgery
Placebo
n=27 Participants
100mL of normal saline to be administered over 5 minutes sugar water/placebo: single preoperative dose prior to surgery
Total
n=55 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Age, Categorical
Between 18 and 65 years
23 Participants
n=5 Participants
26 Participants
n=7 Participants
49 Participants
n=5 Participants
Age, Categorical
>=65 years
5 Participants
n=5 Participants
1 Participants
n=7 Participants
6 Participants
n=5 Participants
Gender
Female
18 Participants
n=5 Participants
22 Participants
n=7 Participants
40 Participants
n=5 Participants
Gender
Male
10 Participants
n=5 Participants
5 Participants
n=7 Participants
15 Participants
n=5 Participants
Region of Enrollment
United States
28 participants
n=5 Participants
27 participants
n=7 Participants
55 participants
n=5 Participants

PRIMARY outcome

Timeframe: 2 hours following end of surgery

Serum concentration of cortisol, CRP, drawn in Post Anesthesia Care unit at 2 hours following surgery were compared with those same levels drawn preoperatively and intraoperatively.

Outcome measures

Outcome measures
Measure
Ibuprofen/Caldolor
n=24 Participants
800mg administered IV in 100cc of normal saline over 5 minutes ibuprofen: single preoperative dose prior to surgery
Placebo
n=25 Participants
100mL of normal saline to be administered over 5 minutes sugar water/placebo: single preoperative dose prior to surgery
Stress Response Inflammation Markers :Cortisol and C Reactive Protein (CRP)
cortisol-PACU
173.6 pg/mL
Standard Deviation 29.5
289.5 pg/mL
Standard Deviation 25.9
Stress Response Inflammation Markers :Cortisol and C Reactive Protein (CRP)
CRP-PACU
17 pg/mL
Standard Deviation 1
17 pg/mL
Standard Deviation 1

SECONDARY outcome

Timeframe: 2 hours postoperatively in PACU

Outcome measures

Outcome measures
Measure
Ibuprofen/Caldolor
n=24 Participants
800mg administered IV in 100cc of normal saline over 5 minutes ibuprofen: single preoperative dose prior to surgery
Placebo
n=25 Participants
100mL of normal saline to be administered over 5 minutes sugar water/placebo: single preoperative dose prior to surgery
Immune Response IL-6
IL-6 PACU
8.3 pg/mL
Interval 0.9 to 80.4
7.7 pg/mL
Interval 0.5 to 59.1
Immune Response IL-6
IL-6 preoperatively
1.4 pg/mL
Interval 0.3 to 22.2
1.2 pg/mL
Interval 0.4 to 14.5
Immune Response IL-6
IL-6 intraoperatively
1.9 pg/mL
Interval 0.4 to 56.4
1.1 pg/mL
Interval 0.3 to 22.7

SECONDARY outcome

Timeframe: preoperatively and -postoperative days 1 and 3

Quality of Recovery-40 has been used to assess postoperative recovery from anesthesia where higher score correlate with improved recovery and well being. The survey has 5 domains: comfort scale ranges 1-60 with higher value indicating greater comfort, emotions scale ranges 1-45 with higher value indicating best emotional state, physical independence scale ranges 1-25 with higher value indicating best independence, patient support scale ranges 1-35 with a higher score indicating greater support and pain scale 1-35 with higher number indicating greater relief from pain. Scoring is done for PART A on a scale of 1-5 (1=very poor=none of the time, worst score, 5=excellent=all of the time, best possible score).PART B on a scale of 1-5 (1=very poor or all the time worse score), 5=excellent or none of the time, best score) Perfect score=200.

Outcome measures

Outcome measures
Measure
Ibuprofen/Caldolor
n=28 Participants
800mg administered IV in 100cc of normal saline over 5 minutes ibuprofen: single preoperative dose prior to surgery
Placebo
n=27 Participants
100mL of normal saline to be administered over 5 minutes sugar water/placebo: single preoperative dose prior to surgery
Quality of Recovery-40
preop comfort
56.5 units on a scale
Standard Deviation 5.69
56.8 units on a scale
Standard Deviation 5.12
Quality of Recovery-40
Preop emotion
42.9 units on a scale
Standard Deviation 3.7
43 units on a scale
Standard Deviation 3.3
Quality of Recovery-40
Preop phy indep
24.8 units on a scale
Standard Deviation 0.7
24.6 units on a scale
Standard Deviation 1.6
Quality of Recovery-40
preop support
34.9 units on a scale
Standard Deviation 0.19
34.5 units on a scale
Standard Deviation 1.4
Quality of Recovery-40
preop pain
34 units on a scale
Standard Deviation 1.3
33.7 units on a scale
Standard Deviation 1.6
Quality of Recovery-40
POD #1 comfort
58. units on a scale
Standard Deviation 2.72
51.2 units on a scale
Standard Deviation 8.6
Quality of Recovery-40
POD #1 emotion
44.4 units on a scale
Standard Deviation 1.3
40.4 units on a scale
Standard Deviation 4.1
Quality of Recovery-40
POD #1phy ind
33.8 units on a scale
Standard Deviation 5.7
23.5 units on a scale
Standard Deviation 3.0
Quality of Recovery-40
POD #1 support
33.6 units on a scale
Standard Deviation 5.7
34.2 units on a scale
Standard Deviation 3.0
Quality of Recovery-40
POD# 1 pain
33.6 units on a scale
Standard Deviation 1.8
27 units on a scale
Standard Deviation 7.4
Quality of Recovery-40
POD#3 comfort
59.4 units on a scale
Standard Deviation 0.9
55 units on a scale
Standard Deviation 4.7
Quality of Recovery-40
POD #3 emotion
44.8 units on a scale
Standard Deviation 0.6
43 units on a scale
Standard Deviation 2.9
Quality of Recovery-40
POD#3 phy ind
24.7 units on a scale
Standard Deviation 0.8
24 units on a scale
Standard Deviation 1.6
Quality of Recovery-40
POD#3 support
34.8 units on a scale
Standard Deviation 0.9
33.6 units on a scale
Standard Deviation 4.2
Quality of Recovery-40
POD#3 pain
34.5 units on a scale
Standard Deviation 0.75
30.4 units on a scale
Standard Deviation 4.6

SECONDARY outcome

Timeframe: preoperative-postoperative day 1 and day 3

This questionnaire contains 9 statements that rate severity of fatigue symptoms. Score 1 indicates strong disagreement with the statement and 7= strong agreement. i.e (I am easily fatigued).Total lowest possible score indicating no fatigue is 9. Total highest possible score is 63 which correlates to severe fatigue, interfering with all activities of daily living.

Outcome measures

Outcome measures
Measure
Ibuprofen/Caldolor
n=28 Participants
800mg administered IV in 100cc of normal saline over 5 minutes ibuprofen: single preoperative dose prior to surgery
Placebo
n=27 Participants
100mL of normal saline to be administered over 5 minutes sugar water/placebo: single preoperative dose prior to surgery
Modified Fatigue Severity Scale
preoperative
16.7 scores on a scale
Standard Deviation 8.87
16.5 scores on a scale
Standard Deviation 7.6
Modified Fatigue Severity Scale
PACU
18.6 scores on a scale
Standard Deviation 11
26.9 scores on a scale
Standard Deviation 14.3
Modified Fatigue Severity Scale
Post op day 1
15.5 scores on a scale
Standard Deviation 9.9
25 scores on a scale
Standard Deviation 13.4
Modified Fatigue Severity Scale
Post op day #3
14.1 scores on a scale
Standard Deviation 6.57
20.8 scores on a scale
Standard Deviation 8.51

SECONDARY outcome

Timeframe: 2 hours post arrival in PACU

.drawn in PACU 2 hours following arrival and compared to preoperative and intraoperative values

Outcome measures

Outcome measures
Measure
Ibuprofen/Caldolor
n=24 Participants
800mg administered IV in 100cc of normal saline over 5 minutes ibuprofen: single preoperative dose prior to surgery
Placebo
n=25 Participants
100mL of normal saline to be administered over 5 minutes sugar water/placebo: single preoperative dose prior to surgery
Immune Response:Serum Concentration of IL-10,
IL-10 PACU
8.3 pg/mL
Interval 0.1 to 32.2
21.8 pg/mL
Interval 0.1 to 113.0
Immune Response:Serum Concentration of IL-10,
IL-10 preoperatively
2.1 pg/mL
Interval 0.0 to 11.2
1.3 pg/mL
Interval 0.23 to 24.2
Immune Response:Serum Concentration of IL-10,
IL-10 intraoperatively
3.3 pg/mL
Interval 0.3 to 76.3
2.5 pg/mL
Interval 0.6 to 26.0

SECONDARY outcome

Timeframe: preoperatively- 2 hours in PACU, Post op day #1, post op day#3

Digits span forward subject is asked to repeat a series of numbers with increasing number of digits forward. Digit span backward subject is asked to repeat a series of numbers backward with increasing number of digits. Correct response is worth 1 point. Maximum of 14 points for each sub score with a total of 28 points for total score

Outcome measures

Outcome measures
Measure
Ibuprofen/Caldolor
n=28 Participants
800mg administered IV in 100cc of normal saline over 5 minutes ibuprofen: single preoperative dose prior to surgery
Placebo
n=27 Participants
100mL of normal saline to be administered over 5 minutes sugar water/placebo: single preoperative dose prior to surgery
Cognitive Recovery.
preop forward total
8.4 units on a scale
Standard Deviation 1.9
8.9 units on a scale
Standard Deviation 1.6
Cognitive Recovery.
preoperative forward max len
6.9 units on a scale
Standard Deviation 0.89
7.08 units on a scale
Standard Deviation 0.8
Cognitive Recovery.
Pre op backward tot
7.7 units on a scale
Standard Deviation 2.08
7.7 units on a scale
Standard Deviation 1.9
Cognitive Recovery.
Preop backward max len
5.5 units on a scale
Standard Deviation 1.1
5.5 units on a scale
Standard Deviation 1.1
Cognitive Recovery.
PACU forward tot
4.7 units on a scale
Standard Deviation 2.6
4.4 units on a scale
Standard Deviation 2.5
Cognitive Recovery.
PACU for max length
4.8 units on a scale
Standard Deviation 1.7
4.4 units on a scale
Standard Deviation 1.8
Cognitive Recovery.
PACU backward tot
4.9 units on a scale
Standard Deviation 2.9
3.1 units on a scale
Standard Deviation 2.1
Cognitive Recovery.
PACU back max length
3.8 units on a scale
Standard Deviation 1.7
3.0 units on a scale
Standard Deviation 1.7
Cognitive Recovery.
Post op #1forward tot
8.7 units on a scale
Standard Deviation 1.6
8.8 units on a scale
Standard Deviation 1.6
Cognitive Recovery.
Post op day 1max length
7.03 units on a scale
Standard Deviation 0.89
7.6 units on a scale
Standard Deviation 0.89
Cognitive Recovery.
Post op #1backward tot
8.2 units on a scale
Standard Deviation 1.6
7.8 units on a scale
Standard Deviation 1.9
Cognitive Recovery.
Post op day #1max length
5.6 units on a scale
Standard Deviation 0.8
5.5 units on a scale
Standard Deviation 1.2
Cognitive Recovery.
Post op #3 forward tot
8.7 units on a scale
Standard Deviation 1.5
8.6 units on a scale
Standard Deviation 1.3
Cognitive Recovery.
post #3 for max length
6.9 units on a scale
Standard Deviation 0.89
6.8 units on a scale
Standard Deviation 0.6
Cognitive Recovery.
post op day #3backward tot
8.6 units on a scale
Standard Deviation 1.8
7.6 units on a scale
Standard Deviation 1.89
Cognitive Recovery.
post op #3 max length
6.03 units on a scale
Standard Deviation 1.09
5.5 units on a scale
Standard Deviation 1.2

SECONDARY outcome

Timeframe: Preoperatively, post operative day 1 and post op day3

15 questions. Score 1 point for each answer selected which indicates depression. Score of 0-5 is normal. A score \>5 suggests depression.

Outcome measures

Outcome measures
Measure
Ibuprofen/Caldolor
n=28 Participants
800mg administered IV in 100cc of normal saline over 5 minutes ibuprofen: single preoperative dose prior to surgery
Placebo
n=27 Participants
100mL of normal saline to be administered over 5 minutes sugar water/placebo: single preoperative dose prior to surgery
Geriatric Depression Scale
preoperative score
0.5 units on a scale
Standard Deviation 1.1
0.7 units on a scale
Standard Deviation 1.4
Geriatric Depression Scale
PACU
0.7 units on a scale
Standard Deviation 0.9
0.9 units on a scale
Standard Deviation 0.7
Geriatric Depression Scale
post op day #1
0.4 units on a scale
Standard Deviation 1.1
0.4 units on a scale
Standard Deviation 0.8
Geriatric Depression Scale
post op day #3
0.2 units on a scale
Standard Deviation 0.8
0.12 units on a scale
Standard Deviation 0.3

POST_HOC outcome

Timeframe: intraoperatively

Outcome measures

Outcome measures
Measure
Ibuprofen/Caldolor
n=24 Participants
800mg administered IV in 100cc of normal saline over 5 minutes ibuprofen: single preoperative dose prior to surgery
Placebo
n=25 Participants
100mL of normal saline to be administered over 5 minutes sugar water/placebo: single preoperative dose prior to surgery
Sympathetic Response: Epinephrine and Norepinephrine Plasma Concentrations
Epinephrine Intraoperatively
0.11 pg/mL
Standard Deviation 0.03
0.23 pg/mL
Standard Deviation 0.05
Sympathetic Response: Epinephrine and Norepinephrine Plasma Concentrations
Norepinephrine Intraoperatively
0.52 pg/mL
Standard Deviation 0.09
1.06 pg/mL
Standard Deviation 0.12

POST_HOC outcome

Timeframe: preoperatively-intraoperatively-postoperatively

Outcome measures

Outcome measures
Measure
Ibuprofen/Caldolor
n=24 Participants
800mg administered IV in 100cc of normal saline over 5 minutes ibuprofen: single preoperative dose prior to surgery
Placebo
n=25 Participants
100mL of normal saline to be administered over 5 minutes sugar water/placebo: single preoperative dose prior to surgery
Immune Response: TNF Alpha
TNF a post op
11.8 pg/mL
Interval 3.6 to 43.1
10.6 pg/mL
Interval 3.6 to 23.0
Immune Response: TNF Alpha
TNF a Preop
12.1 pg/mL
Interval 2.9 to 31.2
11.3 pg/mL
Interval 2.9 to 28.1
Immune Response: TNF Alpha
TNFa Intraop
14 pg/mL
Interval 4.5 to 76.7
8.9 pg/mL
Interval 2.8 to 21.0

POST_HOC outcome

Timeframe: preoperatively-intraoperatively-postoperatively

Outcome measures

Outcome measures
Measure
Ibuprofen/Caldolor
n=24 Participants
800mg administered IV in 100cc of normal saline over 5 minutes ibuprofen: single preoperative dose prior to surgery
Placebo
n=25 Participants
100mL of normal saline to be administered over 5 minutes sugar water/placebo: single preoperative dose prior to surgery
IL-6
IL-6 preoperatively
1.4 pg/mL
Interval 0.3 to 22.2
1.2 pg/mL
Interval 0.4 to 14.5
IL-6
IL-6 intraoperatively
1.9 pg/mL
Interval 0.4 to 56.4
1.1 pg/mL
Interval 0.3 to 22.7
IL-6
IL-6 postoperatively
8.3 pg/mL
Interval 0.9 to 80.4
7.7 pg/mL
Interval 0.5 to 59.1

OTHER_PRE_SPECIFIED outcome

Timeframe: preoperative-intraoperative-postopoperative

IFN y, IL-1B IL-2 were below the limit of detection and no assessments could be made. The lower limit for all cytokine detection was 3.2pg/mL

Outcome measures

Outcome data not reported

Adverse Events

Caldolor/Ibuprofen

Serious events: 1 serious events
Other events: 0 other events
Deaths: 0 deaths

Placebo

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Caldolor/Ibuprofen
n=28 participants at risk
800mg administered IV in 100mL normal saline over 5 minutes prior to surgical incision.
Placebo
n=27 participants at risk
100mL of normal saline to be administered intravenously over 5 minutes prior to surgical incision.
Surgical and medical procedures
patient unable to be extubated at the end of the surgical procedure
3.6%
1/28 • -day of surgery to post operative day 3
0.00%
0/27 • -day of surgery to post operative day 3

Other adverse events

Adverse event data not reported

Additional Information

Alex Bekker, MD, PhD

Rutgers/State University of New Jersey (NJMS)

Phone: 973 972-5007

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place